Heparin - PfizerAlternative Names: Heparin sodium - Pfizer
Latest Information Update: 13 Jul 2015
At a glance
- Originator Pfizer
- Class Anti-infectives; Anti-inflammatories; Antithrombotics; Bronchodilators; Heparins; Mucolytics
- Mechanism of Action Thrombin inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Disseminated intravascular coagulation; Peripheral arterial occlusive disorders; Pulmonary embolism; Thromboembolism; Venous thrombosis
Most Recent Events
- 15 Mar 2016 Biomarkers information updated